Zoloft and Rifampin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zoloft (sertraline hydrochloride) and Rifampin (rifampin). Common drug interactions include skin induration among females and immune system disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Zoloft and Rifampin. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Zoloft?

Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 138,798 Zoloft users. Check the latest studies of Zoloft.

What is Rifampin?

Rifampin has active ingredients of rifampin. It is often used in tuberculosis. eHealthMe is studying from 12,339 Rifampin users. Check the latest studies of Rifampin.



On Jul, 10, 2026

62 people who take Zoloft and Rifampin together, and have interactions are studied.

Zoloft and Rifampin drug interactions.

What are the common drug interactions of Zoloft and Rifampin, by gender? *:

female:

  1. Skin induration (an abnormally hard spot or area on the skin)
  2. Urinary tract infection bacterial
  3. Vasculitis (inflammation of a blood vessel or blood vessels)
  4. Alanine aminotransferase increased
  5. Alopecia (absence of hair from areas of the body)
  6. Arthralgia (joint pain)
  7. Arthropathy
  8. Aspartate aminotransferase increased
  9. Ataxia (loss of full control of bodily movements)
  10. Atypical mycobacterial infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis)

male:

  1. Immune system disorder
  2. Chronic kidney disease
  3. Diabetic complication
  4. Impaired work ability
  5. Staphylococcal infection (an infection with staphylococcus bacteria)
  6. Abdominal pain
  7. Back pain
  8. Blood glucose increased
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Splenomegaly (enlargement of spleen)

What are the common drug interactions of Zoloft and Rifampin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood glucose increased

20-29:

n/a

30-39:

  1. Dyspnoea (difficult or laboured respiration)
  2. Feeling hot
  3. Flushing (the warm, red condition of human skin)
  4. Nausea (feeling of having an urge to vomit)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Alopecia (absence of hair from areas of the body)
  7. Arthralgia (joint pain)
  8. Ataxia (loss of full control of bodily movements)
  9. Chest pain
  10. Clamminess (moist, sticky, and cold to the touch)

40-49:

  1. Haemoglobin increased
  2. Hyperlipidaemia (presence of excess lipids in the blood)
  3. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  4. Mitral valve incompetence (inefficient heart valve)
  5. Muscular weakness (muscle weakness)
  6. Myalgia (muscle pain)
  7. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Neck pain
  10. Obesity (having too much body fat)

50-59:

  1. Hypersensitivity
  2. Burning sensation
  3. Chest pain
  4. Chills (felling of cold)
  5. Chronic kidney disease
  6. Coagulopathy (blood's ability to clot is impaired)
  7. Diarrhoea
  8. Disturbance in attention
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

60+:

  1. International normalised ratio increased
  2. Dyspnoea (difficult or laboured respiration)
  3. Blood glucose increased
  4. Cardiac arrest
  5. Drug dependence
  6. Drug effect decreased
  7. Drug ineffective
  8. Epistaxis (bleed from the nose)
  9. Heart rate increased
  10. Hypertension (high blood pressure)

What are the existing conditions these people have? *

  1. Ankylosing Spondylitis (type of arthritis affecting the spine): 10 people, 16.13%
  2. Pain: 8 people, 12.90%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 11.29%
  4. Fever: 7 people, 11.29%
  5. High Blood Pressure: 6 people, 9.68%
  6. Sleep Disorder: 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Zoloft and Rifampin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zoloft and Rifampin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zoloft:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rifampin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zoloft and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rifampin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sertraline hydrochloride and rifampin (the active ingredients of Zoloft and Rifampin, respectively), and Zoloft and Rifampin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: